In an expert interview filmed at AAO 2018, Dr Deepinder Dhaliwal discusses the difference between Descemet membrane endothelial keratoplasty (DMEK) and descemetorhexis without endothelial keratoplasty (DWEK) for the treatment of Fuchs’ dystrophy. Dr Dhaliwal explains that in her recent study, corneal oedema was shown to clear on its own, in approximately 7 weeks, after a 4 mm descemetorhexis centred on the visual axis. She also describes that although patients may experience faster results in, terms of vision improvement, with DMEK, this procedure may incur more post-operative complications, such as increased intraocular pressure, when compared to DWEK.
In part 2 of her interview, Dr Deepinder Dhaliwal describes which patients make ideal candidates for descemetorhexis without endothelial keratoplasty (DWEK), and those that are contraindicated. Dr Dhaliwal also explains why some studies may have reported poor outcomes with DWEK. Reasons such as failure to provide rho kinase inhibitors as part of the post-operative management, or those with advanced corneal disease.
1. What are the limitations of the use of Descemet membrane endothelial keratoplasty (DMEK) for patients with Fuchs’ endothelial corneal dystrophy? (0:11)
2. What is the rationale for the use of descemetorhexis without endothelial keratoplasty (DWEK)? (0:50)
3. What were the findings of your recent study comparing the two treatment modalities? (1:47)
4. Which patients are best suited to treatment with descemetorhexis without endothelial keratoplasty (DWEK) and what are the contraindications? (0:11)
5. Why have some studies reported poor outcomes for DWEK? (1:05)
Speaker disclosures: Deepinder Dhaliwal has nothing to disclose in relation to this interview.
Filmed at the American Academy of Ophthalmology (AAO) 2018 Annual Meeting, Chicago, IL, US, 27–30 October 2018.
Share this Video
Related Videos In Corneal Disorders
Karolinne M Rocha, Kiaweh Eye 2021: Corneal Epithelial Thickness Mapping
It was a pleasure to catch up with Karolinne M Rocha (Medical University of South Carolina, SC, USA) about advances in corneal epithelial thickness mapping technology in the past year. How has corneal epithelial thickness mapping helped in the detection of subclinical early-stage keratoconus? (00:19) What have been the major advances in corneal epithelial thickness […]
Karolinne M Rocha, Kiaweh Eye 2021: The Role of the Corneal Epithelium and Methods to Assess Corneal Epithelial Thickness
We were delighted to speak with Karolinne M Rocha (Medical University of South Carolina, SC, USA) about the role of the corneal epithelium in the refractive system of the eye, and the usefulness of knowledge of the corneal epithelial thickness profile in cataract surgery. What is the role of the corneal epithelium in the refractive […]
Jorge L Alió, EGS 2020 – Corneal Regeneration, Will It Be a Reality in 2021?
We were delighted to talk with our Editorial Board member, Jorge L. Alió (Miguel Hernández University of Alicante, Elche, Spain) about the recent technological advances in corneal regeneration. Questions Could you tell us a little about the challenges and opportunities of corneal regeneration? (0:05) What have been the most exciting recent technological advances in corneal […]
Journal articles and more to your inbox
Get the latest clinical insights from touchOPHTHALMOLOGYSign me up!